Peritoneal Dialysis
104
7
10
46
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
4 terminated out of 104 trials
92.0%
+5.5% vs benchmark
21%
22 trials in Phase 3/4
4%
2 of 46 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 46 completed trials
Clinical Trials (104)
Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis
Predicting Peritoneal Kt/Vurea Based on Single-Exchange Dialysate Effluent
Combined Aerobic and Resistance Exercise in Peritoneal Dialysis Patients
Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study
Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients
Nocturnal APD vs. CAPD in Non-diabetic ESKD
Apixaban in Subjects With Peritoneal Dialysis
Continuous Glucose Monitoring in Dialysis Patients With Diabetes
Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease
Bisacodyl Oral for Lowering Dysfunction (of Tenckhoff Catheter)
Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans
Care Burden in Peritoneal Dialysis Caregivers.
Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients
Multi-omics Study of Peritoneal Dialysis Effluent to Explore Biomarkers of Peritoneal Fibrosis
Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
Formative Usability Testing Study of a Novel Medical Device for Peritoneal Dialysis (WEAKID)
Pharmacokinetics of Meropenem and Aztreonam After Intraperitoneal Administration Via Cycler-therapy in APD Patients Without Peritonitis
Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients
Peritoneal Dialysis Daily Versus Six Days Per Week
Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.